We use cookies to understand how you use our site and to improve your experience. ), Accuray has received 317 “underperform” votes. View which stocks have been most impacted by COVID-19.
There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Stocks To Buy - Why Is This Metal Taking Off? An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Looking for new stock ideas? ET on the same day.
NYSE and AMEX data is at least 20 minutes delayed. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
This is an estimated date of earnings release.
View Accuray's Short Interest. There may be delays, omissions, or inaccuracies Accuray's stock was trading at $2.27 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Delayed quotes by Sungard. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. ARAY 2.70 0.03 (1.10%). The medical equipment provider earns $3.83 million in net income (profit) each year or ($0.08) on an earnings per share basis. On a year-over-year basis, revenues fell 8.6%. Since then, ARAY stock has increased by 23.3% and is now trading at $2.80. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Accuray's mailing address is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. View our earnings forecast for Accuray. Accuray has only been the subject of 1 research reports in the past 90 days. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Currently, 5.0% of the shares of the company are short sold. View institutional ownership trends for Accuray. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The medical equipment provider can be reached via phone at 408-716-4600 or via email at [email protected]. Accuray has received 314 “outperform” votes. Real time Accuray (ARAY) stock price quote, stock graph, news & analysis.
© 2020 Verizon Media.
Instead of barely squeezing a paltry $150 out of the market… you could have had the chance to make $29,100!
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. If it isn't grown, it has to be mined. The company also offers optional hardware and software, technical enhancements, and upgrades to the CyberKnife and TomoTherapy System, as part of its multi-year service plans.The CyberKnife Systems are fully robotic stereotactic radiosurgery systems (SRS) and stereotactic body radiation therapy systems (SBRT) used to treat multiple types of cancer and tumors in the body. Export data to Excel for your own analysis.
Research, Inc. nor its Information Providers can guarantee the accuracy, To see all exchange delays and terms of use please see disclaimer. Chief Commercial Officer and Sr. VP of R&D, Start Your Risk-Free Trial Subscription Here, Enphase Energy (NASDAQ:ENPH) Stock a Buy: Powering Homes With Alternative Energy, Why Progressive Can Produce More Than Just Witty Insurance Commercials, Walgreens Boots Alliance (NASDAQ:WBA) Is A More Compelling Buy Than Ever, General Electric (NYSE:GE) Is A Bargain Basement Buy, Infosys (NYSE: INFY); The Stock That Offers 60% Annual Returns And A Dividend, LI Auto (NYSE: LI) Stock is a Chinese EREV and Autonomous Buy Trade. NASDAQ data is at least 15 minutes delayed. also free. View all competitors. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.53% per year. Get the latest Accuray Incorporated ARAY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Furthermore, ARAY is technically a penny stock at prices near $2.50. Accuray trades on the NASDAQ under the ticker symbol "ARAY.". Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Accuray reports through two major segments — Product and Service.For the fiscal year, Product revenues were $167.3 million (43.7% of net sales), down 14.9% year over year. Since then, ARAY shares have increased by 34.8% and is now trading at $3.06. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. The company was incorporated in 1990 and is headquartered in Sunnyvale, California. Learn more. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Learn about financial terms, types of investments, trading strategies and more. The CyberKnife Systems include: the CyberKnife G4, which includes the Fixed collimator; CyberKnife VSI System, which includes the Fixed and Iris collimators and the new CyberKnife M6 Series System, that comes in configurations with option of Fixed collimator, Iris collimator, and a MultiLeaf collimator, or MLC.In the past, Accuray acquired TomoTherapy that develops advanced radiation therapies to treat multiple cancer types. © American Consumer News, LLC dba MarketBeat® 2010-2020. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. ZacksTrade and Zacks.com are separate companies.
publicly available sources. Company insiders that own Accuray stock include Andrew J Kirkpatrick, Jesse Chew, Joseph E Whitters, Joshua Levine, Patrick Spine and Shigeyuki Hamamatsu. Accuray's stock was trading at $2.27 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. (Add your “underperform” vote.). Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank.
Instead of buying stocks and praying they go up... my ""Money Multiplier"" strategy could've helped you put 194x MORE money into your account… over the same time! "document.write('
Identify stocks that meet your criteria using seven unique stock screeners. Accuray Inc. (ARAY) CEO Joshua Levine on Q3 2020 Results - Earnings Call Transcript SA Transcripts Tue, Apr. Top institutional shareholders include Assenagon Asset Management S.A. (0.68%) and Diversified Trust Co (0.02%). Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. View Accuray's earnings history. . The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. View Accuray Incorporated ARAY investment & stock information. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Accuray does not have a long track record of dividend growth. All rights reserved. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. View which stocks have been most impacted by COVID-19.
Accuray employs 932 workers across the globe. Accuray Incorporated. Shares of ARAY can be purchased through any online brokerage account. Accuray's management team includes the following people: Repeat Stocks Creating A “Printing Press” For Traders.
Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Some companies that are related to Accuray include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and Steris (STE).
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. in the Information. The monthly returns are then compounded to arrive at the annual return. Their forecasts range from $6.00 to $10.00. The P/E ratio of Accuray is 102.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 19.81. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. Real time prices by BATS. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Product revenues include sales of linear accelerators (linacs) for other uses. Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2021, ended September 30, 2020, after the market close on Thursday, October 29, 2020. Accuray is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. Sign-up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Click here to watch the full series. The P/E ratio of Accuray is 102.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.73. Copyright 2020 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Visit www.zacksdata.com to get our data and content for your mobile app or website. Want to see which stocks are moving? The technique has proven to be very useful for finding positive surprises. Learn more. According to analysts' consensus price target of $8.00, Accuray has a forecasted upside of 161.4% from its current price of $3.06. Only 4.00% of the stock of Accuray is held by insiders. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings. Get daily stock ideas top-performing Wall Street analysts. Please log in to your account or sign up in order to add this asset to your watchlist. Starting with just $15,000 Kyle Dennis Turned His Money Into Over $10 Million and He’s Only 30. Accuray has a market capitalization of $279.07 million and generates $382.93 million in revenue each year. Product revenues include sales of linear accelerators (linacs) for other uses.
28 Accuray FQ3 non-GAAP EBITDA up 69%; shares up 10% after hours View analyst ratings for Accuray.
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accuray in the last year.